Phoenix Analysis & Design Technologies (PADT) and M-Tech Industrial are highlighting the use of the Flownex Simulation Environment software tool in the mining industry by exhibiting and presenting at the 2014 Society of Mining Engineering (SME) Meeting and Exhibit. From its early beginnings, Flownex SE has been a powerful tool for mining engineers who wish to model thermal-fluid systems in mining including water, ventilation, compressed air, and slurry systems. Companies like AngloGold Ashanti and Anglo American use Flownex SE to analyze mining subsystems in a virtual world in order to achieve maximum potential and savings.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/64472-phoenix-analysis-design-flownex-simulation-software-tool-mining-exhibit
Twenty-two vehicles earn the Insurance Institute for Highway Safety's highest safety award for 2014, TOP SAFETY PICK+, thanks to a high level of protection in crashes and the availability of front crash prevention technology to avoid many collisions in the first place. An additional 17 earn TOP SAFETY PICK by meeting the crashworthiness criteria alone.
IIHS is using new criteria for the awards this year. TOP SAFETY PICK requires good performance in the Institute's moderate overlap front, side, roof strength and head restraint tests and, for the first time, good or acceptable performance in the small overlap front test introduced in 2012. The same level of performance in those tests, along with at least a basic rating for front crash prevention, is required for the higher accolade, TOP SAFETY PICK+.
Three and a half years after beginning a clinical trial which demonstrated the first successful and sustained use of genetically engineered T cells to fight leukemia, a research team from the Perelman School of Medicine at the University of Pennsylvania and the Children’s Hospital of Philadelphia will today announce the latest results of studies involving both adults and children with advanced blood cancers that have failed to respond to standard therapies. The findings from the first 59 patients who received this investigational, personalized cellular therapy, known as CTL019, will be presented during the American Society of Hematology’s Annual Meeting and Exposition in New Orleans.
To view Multimedia News Release, go to http://www.multivu.com/mnr/64691-penn-medicine-reports-research-leukemia-patients-cellular-therapy-ctl019
CHS Inc., the nation’s leading cooperative and a global energy, grains and foods company, is committed to continued growth that will drive economic value to its farmer owners and the rural communities in which they live, its leaders told attendees at its recent annual meeting.
“Our ultimate responsibility is to invent the CHS of the future by making the decisions, executing the investments and managing the financial health of this company in a manner that not only adds value for you today, but continues to pay off 10 and 20 years down the road,” CHS President and Chief Executive Officer Carl Casale told attendees. “Ultimately, it’s about taking actions today that will benefit tomorrow’s owner, the generations that are now playing in farm yards or buying their first blue FFA jackets.”
To view the Multimedia News Release, go to http://www.multivu.com/mnr/58034-chs-inc-putting-future-first-for-cooperative-farmer-owners
